Thu, November 10, 2022

Matt O"Brien Maintained (TELA) at Buy with Decreased Target to $15 on, Nov 10th, 2022

Matt O"Brien of Piper Sandler, Maintained "TELA Bio, Inc." (TELA) at Buy with Decreased Target from $20 to $15 on, Nov 10th, 2022.

Matt, nor any peers, have made any analyst calls on TELA in the last 4 months.